Officials at Rentschler Biopharma emphasize that biologics (cell culture-based therapeutic proteins) remain central to its operations.

Insights into the structures could lead to improved treatment strategies for transthyretin amyloidosis, a progressive, fatal disease in men.

CEO Serge Saxonov, PhD, says provider of single cell, spatial, and in situ instruments expects to see benefits from sales ...

Scientists say identification of two epigenetically different states in mouse model opens door to "entirely new world of ...

It’s time for a new era of public health—where vaccines are seen as both a scientific triumph and a shared commitment to well ...

The effective use of ADA in bioprocessing, though, requires a multidisciplinary team, from a program lead and subject-matter ...

Results prove that inversions can be generated in plants without causing further unwanted changes in the expression of genetic information.

Reusing buffers in downstream operations would help biopharmaceutical manufacturers significantly reduce water consumption, making production more sustainable and cost efficient.

A new, streamlined AAV purification process that is both universal and scalable could ease commercialization constraint.

Lumi is available for early-stage process development. Reach Industries hopes to eventually offer the system for use in GMP compliancy.

People with diabetes have a higher risk of developing Alzheimer's disease (AD) raising a possible link between the cells that ...

Taking longer to enter the dream phase can disrupt the ability to consolidate memories and interfere with emotion regulation.